Funding round
Genetic Growth
Reported as "Growth Equity"
Genetic, which works in pharmaceutical product research and development in Fisciano, raised $770M in a Growth round announced on 20 May 2025. 2 firms took part.
$770M
Amount raised
680,000,000 EUR converted
Not disclosed
Post-money valuation
2
Investors
no lead named
Valuation
What this round says about the price
Genetic did not disclose a valuation in this round. It is Genetic's first venture round on record, 35 years after it was founded in 1990. No later venture round is on record for Genetic.
Genetic's funding rounds
This is the only venture round on record for Genetic.
- Growth this round 20 May 2025 $770M
Investors
Who put money in
2 firms took part; no lead investor was named.
Investors
- NB Renaissance new investor
- NB Aurora new investor
Comparable rounds
How it compares
30 Growth rounds in Pharmaceutical Products within a year either side disclosed an amount; the median was $54M, and this round was 14 times the median. The closest in time, other companies' Growth rounds in Pharmaceutical Products:
| Company | Announced | Amount | Post-money | Led by |
|---|---|---|---|---|
| Pharmaceutical Products | 15 May 2025 | $28M | not disclosed | not named |
| Pharmaceutical Products | 30 Jun 2025 | $252M | not disclosed | Coller Capital |
| Pharmaceutical Products | 3 Apr 2025 | $102M | not disclosed | not named |
| Pharmaceutical Products | 26 Apr 2025 | $15M | not disclosed | CDG Invest Growth |
| Pharmaceutical Products | 1 Mar 2025 | $60M | not disclosed | not named |
| Pharmaceutical Products | 18 Aug 2025 | $46M | not disclosed | Mellby Gård |
| Verdiva Bio Pharmaceutical Products | 19 Sep 2025 | $457M | not disclosed | Forbion and General Atlantic |
| Pharmaceutical Products | 13 Jan 2025 | $100M | $1.40B | Quadria Capital |
Sources
Where this comes from
Reported by 2 sources. The deal data marks this round as not yet confirmed by an official announcement. Unconfirmed
Questions
Frequently asked
How much did Genetic raise in its Growth round?
Genetic raised $770M in its Growth round, announced in May 2025.
Which investors took part in Genetic's Growth round?
NB Renaissance and NB Aurora.
What was Genetic's valuation at the Growth round?
It was not disclosed.
How does it compare with other Growth rounds in Pharmaceutical Products?
30 Growth rounds in Pharmaceutical Products within a year either side disclosed an amount; the median was $54M, and this round was 14 times the median.